UAB Digital Repository of Documents 1 records found  Search took 0.00 seconds. 
16 p, 911.4 KB Geometrical Measures Obtained from Pretreatment Postcontrast T1 Weighted MRIs Predict Survival Benefits from Bevacizumab in Glioblastoma Patients / Molina, David (Universidad de Castilla-La Mancha (Ciudad Real)) ; Pérez Beteta, Julián (Universidad de Castilla-La Mancha (Ciudad Real)) ; Martínez González, Alicia (Universidad de Castilla-La Mancha (Ciudad Real)) ; Sepúlveda, Juan M. (Hospital Universitario 12 de Octubre (Madrid)) ; Peralta, Sergi (Hospital Universitari Sant Joan de Reus (Tarragona)) ; Gil Gil, Miguel J. (Institut Català d'Oncologia) ; Reynes, Gaspar (Hospital Universitario La Fe (València)) ; Herrero, Ana (Hospital Universitario Miguel Servet (Zaragoza)) ; De Las Peñas, Ramón (Consorci Hospitalari Provincial de Castelló) ; Luque, Raquel (Hospital Universitario Virgen de las Nieves (Granada)) ; Capellades, Jaume (Hospital del Mar (Barcelona)) ; Balañá, Carmen (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Pérez García, Víctor M. (Universidad de Castilla-La Mancha (Ciudad Real))
Background: Antiangiogenic therapies for glioblastoma (GBM) such as bevacizumab (BVZ), have been unable to extend survival in large patient cohorts. However, a subset of patients having angiogenesis-dependent tumors might benefit from these therapies. [...]
2016 - 10.1371/journal.pone.0161484
PloS one, Vol. 11 Núm. 8 (August 2016)  

Interested in being notified about new results for this query?
Set up a personal email alert or subscribe to the RSS feed.